BJA Advance Access originally published online on February 20, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Journal of Anaesthesia, 2004, Vol. 92, No. 4 552-557
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia
Laboratory Investigations |
Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium
1 University of Caen: UPRES EA 3212, IFR47; Département d‘Anesthésie Réanimation, Centre Hospitalier Universitaire (CHU), Côte de Nacre, Caen, France. 2 University of Caen, CNRS: UMR-6551, IFR47; CYCERON Centre, Boulevard Henri Becquerel, BP 5229, F-14074 Caen Cedex, France
*Corresponding author. E-mail: haelewyn@yahoo.fr
Background. We compared the cardioprotective effects of 1 minimum alveolar concentration (MAC) desflurane administered before, during or after ischaemia, or throughout the experiment (before, during and after ischaemia) on myocardial infarct size following 30 min occlusion of the left anterior descending coronary artery and 3 h reperfusion in adult rats.
Methods. Fifty male Sprague–Dawley rats were anaesthetized with pentobarbital, intubated and mechanically ventilated. Blood gases, pH and body temperature (37.5–38°C) were controlled. Heart rate and arterial pressure were measured continuously. Animals were randomly assigned to the following groups (n=10 in each group): pentobarbital only (‘Pento’); 15 min desflurane administration followed by 10 min of washout before 30 min ischaemia and 3 h reperfusion (‘Precond’); 30 min desflurane administration during ischaemia period (‘Isch’); desflurane administration during the 15 first min of reperfusion (‘Reperf’) and desflurane administration throughout the experiment (before, during and after ischaemia; ‘Long’). Volumes at risk and infarct sizes were assessed by Indian ink and with 2,3,5-triphenyltetrazolium chloride staining, respectively.
Results. Physiological parameters and volumes at risk were not significantly different between groups. In the Pento group, mean myocardial infarct size was 65 (SD 15)% of the volume at risk; myocardial infarct size was reduced to a significant and comparable extent in the desflurane-treated groups (Precond 42 (14)%; Isch 34 (11)%; Reperf 41 (15)%; Long 33 (10)%; P<0.0002 vs Pento group).
Conclusions. In rats, desflurane 1 MAC significantly decreased myocardial infarct size whatever the period and duration of administration.
Br J Anaesth 2004; 92: 552–7
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Li, X. Zhang, B. Zhu, and Z. Xue Desflurane Preconditioning Inhibits Endothelial Nuclear Factor-{kappa}-B Activation by Targeting the Proximal End of Tumor Necrosis Factor-{alpha} Signaling Anesth. Analg., May 1, 2008; 106(5): 1473 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Obal, S. Dettwiler, C. Favoccia, H. Scharbatke, B. Preckel, and W. Schlack The Influence of Mitochondrial KATP-Channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat In Vivo Anesth. Analg., November 1, 2005; 101(5): 1252 - 1260. [Abstract] [Full Text] [PDF]
|
|